1 Meta-Analysis 1998
A systematic review and meta-analysis found yohimbine superior to placebo for erectile dysfunction.
Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. Ernst E et al. · The Journal of urology (1998)
Yohimbine significantly more effective than placebo for ED Adverse events were mostly mild and reversible Supports yohimbine (the isolated alkaloid) for ED specifically 2 Systematic Review 2022
A systematic review described yohimbine as a pharmacological probe (an alpha-2 antagonist that raises noradrenaline) in alcohol research.
Yohimbine as a pharmacological probe for alcohol research: a systematic review of rodent and human studies. Curley DE et al. · Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology (2022)
Yohimbine reliably increases noradrenergic activity and arousal Used experimentally to provoke stress responses Illustrates its sympathomimetic mechanism 3 Systematic Review 2017
Evidence-based review of neurogenic orthostatic hypotension noted yohimbine's blood-pressure-raising (sympathomimetic) action.
Evidence-based treatment of neurogenic orthostatic hypotension and related symptoms. Eschlböck S et al. · Journal of neural transmission (Vienna, Austria : 1996) (2017)
Yohimbine raises blood pressure via sympathetic activation Relevant to both therapeutic use and adverse-effect risk Effect is dose-dependent 4 Review 2011
An evidence review of erectile dysfunction treatments discussed yohimbine among oral options with limited efficacy versus PDE5 inhibitors.
Erectile dysfunction. Khera M et al. · BMJ clinical evidence (2011)
Yohimbine has modest ED efficacy PDE5 inhibitors are first-line Yohimbine's role is secondary 5 Systematic Review 2025
A systematic review of pharmacological interventions for male anorgasmia included yohimbine among studied agents.
Pharmacological interventions in primary or secondary male anorgasmia: A systematic review. Gómez-Bueno MP et al. · Actas urologicas espanolas (2025)
Yohimbine among agents assessed for anorgasmia Evidence base limited 6 Systematic Review Cited 19×2021 An evidence-based analysis of pre-workout supplement ingredients reviewed yohimbine, noting limited performance evidence and cardiovascular cautions.
A systematic review and evidence-based analysis of ingredients in popular male testosterone and erectile dysfunction supplements. Kuchakulla M et al. · International journal of impotence research (2021)
Limited evidence for yohimbine in performance products Cardiovascular and anxiety risks flagged Often combined with stimulants, increasing risk 7 Systematic Review Cited 29×2023 A systematic review of supplements for athletic performance assessed common pre-workout ingredients including yohimbine.
Effects of dietary supplements on athletic performance in elite soccer players: a systematic review. Abreu R et al. · Journal of the International Society of Sports Nutrition (2023)
Insufficient performance evidence for yohimbine Stimulant ingredients carried safety considerations Quality of evidence variable 8 RCT 2022
A randomized trial found the alpha-2 antagonist yohimbine modulated memory consolidation, reflecting its noradrenergic activity.
Alpha-2 Adrenoreceptor Antagonist Yohimbine Potentiates Consolidation of Conditioned Fear. Sperl MFJ et al. · The international journal of neuropsychopharmacology (2022)
Yohimbine affected noradrenaline-dependent memory processes Mechanistic/experimental endpoint Confirms central noradrenergic action 9 Open-Label 2025
A pharmacokinetic study characterized single-dose and steady-state yohimbine exposure.
Single-dose and steady-state pharmacokinetics of clomipramine, yohimbine and clomipramine/yohimbine combination: A clinical drug-drug interaction study. Leutzendorff A et al. · British journal of clinical pharmacology (2025)
Described yohimbine absorption and clearance Highlights variable metabolism between individuals Pharmacokinetic focus 10 Pilot 1995
An early controlled study examined topical yohimbine for localized fat reduction.
Topical fat reduction. Greenway FL et al. · Obesity research (1995)
Explored localized fat-reduction effect Not robust evidence for systemic fat loss